Novel Combination Therapies for the Treatment of Bladder Cancer

Bladder cancer is the ninth most frequently diagnosed cancer world-wide and ranks 13th in cancer-related deaths. Two tremendous breakthroughs in bladder cancer therapy over the last decades are the approval of immune checkpoint inhibitors(ICIs)and the fibroblast growth factor receptor tyrosine kinas...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Peng, Mei, Xiao, Di, Bu, Yizhi, Long, Jiahui, Yang, Xue, Lv, Shuhe, Yang, Xiaoping
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873600/
https://ncbi.nlm.nih.gov/pubmed/33585182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.539527
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia